If you have zero blood type then your genetic heredity offers you the opportunity to be strong, productive, have a long life and be optimistic.
This blood type is original type of our ancestors who were smart and aggressive predators. The persons with this blood type have important role in the society.
While scientists have had success in the past printing structures like “bionic ears,” a clear path to making functional internal organs and tissue hasn’t really emerged. However, researchers at the University of Florida in Gainesville have developed a way of printing complex objects in gel, a method that could help pave the way to 3D-printed organs in the future.
The hard thing about printing intricate organic structures like blood vessels and complicated organs is that they collapse under their own weight before they solidify. The gel here, which is made of an acrylic acid polymer, acts as a scaffold to hold the structure in place during the printing process. That approach has already allowed the team to print with organic materials — and even make a replica of a human brain.
Printing in gel isn’t an entirely new idea. And, of course, the method isn’t perfect. For one thing, using inorganic gel as a scaffold can’t keep organic tissue alive. For another, printing very small objects could lead to some particles slipping through the material. However, it’s certainly a solid step forward on the way to printing organs for patients in need someday.
Researchers have developed a new technique to produce a 3D ‘micro-printed’ array of needles capable of drug delivery. The technique would offer a pain-free drug delivery device that would allow drugs to diffuse within the body as the biomaterial device degrades in the body. This offers treatments for a wide range of diseases, including melanoma cancers.
The results are published today, Wednesday 30th September, in the journal Biofabrication .
The researchers, based at the University of Akron and the University of Texas, report producing a drug-loaded array for transdermal delivery of a chemotherapeutic drug, fabricated using microstereolithography. The arrays consisted of 25 poly(propylene fumarate) microneedles, each needle having a tip and base diameter of 20 µm and 200 µm, respectively, and a height of 1 mm.
Visionary Liz Parrish shares some of the remarkable ways that genetic therapies are helping humanity transcend disease, aging and physical limitations. We discuss some of the current applications of gene therapy, what we can reasonably expect given the rate of progress and some of the moral implications of this science. If you’re anything like us, you’ll be astounded to hear about this work; it can already make you stronger and faster, and it may help future generations live upwards of 400 years!
Click to download the episode directly (right click, then click save as) Subscribe to the podcast on iTunes. Subscribe to the podcast on Stitcher.
“Known as “the woman who wants to genetically engineer you,” Elizabeth Parrish is the CEO of BioViva USA Inc ™ she is a humanitarian, entrepreneur and innovator and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of gene therapy, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA) whose mission is to further scientific understanding of biological complexity and the nature and origins of human disease. She is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of the American Longevity Alliance (ALA) a 501©(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine with the aim to get governments to consider aging a disease.” –Blurb taken from Liz’ LinkedIn Profile.
A new hydrogel protects stem cells inside the body, making existing therapies a lot more effective.
Scientists believe they have found a better pair of molecular scissors to use with the genome-editing technique that is revolutionizing biology.
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2014 (credit: Behavorial Risk Factor Surveillance System/CDC)
A molecule known as MnTBAP has rapidly reversed obesity in mice and could be effective for humans in the future, according to researchers from Skidmore College and the Perelman School of Medicine at the University of Pennsylvania.
A paraplegic man who was paralysed for five years has walked again on his own two feet, thanks to a new kind of brain-computer interface that can reroute his thoughts to his legs, bypassing his spinal cord entirely.
The anonymous man, who experiences complete paralysis in both legs due to a severe spinal cord injury (SCI), is the first such patient to demonstrate that brain-controlled overground walking after paraplegia due to SCI is feasible.
“Even after years of paralysis, the brain can still generate robust brain waves that can be harnessed to enable basic walking,” one of the researchers, Zoran Nenadic from the University of California, Irvine in the US, said in a press release. “We showed that you can restore intuitive, brain-controlled walking after a complete spinal cord injury.”
